Benchling Deepens AI-Driven Biotech Platform With Integrated CRO Ordering and Data Loop

New updates have been reported about Benchling.

Benchling has launched direct ordering for biological materials and CRO services from within its AI-driven R&D platform, tightening the link between digital experiment design and physical execution. The new capability connects scientists’ in-platform designs to services from Twist Bioscience, Adaptyv, and Ginkgo Bioworks, allowing users to design constructs, place orders, and receive structured results without leaving Benchling.

Each order is tied to full experimental context, including targets, project history, in silico model parameters, and prior data, creating a continuous feedback loop essential for AI-led biopharma discovery. Benchling positions this as a solution to the bottleneck between high-throughput computational design, such as generating thousands of antibody candidates, and the slower processes of ordering, coordination with CROs, and reintegrating results.

The integration with Twist covers both digital data and physical products such as gene fragments and antibody-related services, which are shipped directly to customers’ labs and automatically linked back to originating designs. Adaptyv adds high-throughput wet-lab validation for protein engineering, returning expression, binding, and developability data in a structured format within weeks, while Ginkgo contributes large-scale antibody developability and functional genomics data.

Benchling embeds this ordering workflow into its existing notebook, sequence editor, and registry tools so teams can design sequences using in-platform models like BoltzGen or external pipelines, run manufacturability checks and assay selections, then submit and track orders end-to-end. Results flow back into Benchling as structured, searchable data, ready for downstream analysis and model training, reinforcing the platform’s positioning as a core data and workflow layer for biotech R&D.

The company is also extending its AI and automation ecosystem via connectors to literature and data sources such as Elicit, GXL, Seqera, Quilt, and internal knowledge bases, and by linking to HighRes robotic workcells for automated bench execution. Early access ordering with Twist (for gene fragments) and Adaptyv is available now for all Benchling customers, with Ginkgo integration slated to expand later this year, signaling Benchling’s push to become the central operating system for AI-native biopharma labs.